login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
All US stocks
All Canadian stocks
All European stocks
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Account
Disclaimer
Affiliate
Contact
Privacy
Catabasis Pharma (CATB) Stock News
NASDAQ:CATB - Nasdaq -
8.54
-0.64 (-6.97%)
After market: 8.63
+0.09 (+1.05%)
Summary
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
CATB Latest News, Press Relases and Analysis
All
Press Releases
4 years ago - By: Benzinga
Catabasis Renames As Astria Therapeutics With New Disease Focus
4 years ago - By: Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals Announces New Company Name, Astria Therapeutics, Highlighting New Company Focus
4 years ago - By: Benzinga
- Mentions:
BLDE
ALKS
VLTA
SBUX
...
Benzinga's Top Ratings Upgrades, Downgrades For September 2, 2021
4 years ago - By: Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals Reports Second Quarter 2021 Financial Results and Provides a Corporate Update
4 years ago - By: Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals to Present at 2021 Wedbush PacGrow Healthcare Conference
4 years ago - By: Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals To Present At Ladenburg Thalmann 2021 Healthcare Conference
4 years ago - By: StockNews.com
- Mentions:
SRNE
2 Biotech Stocks Wall Street Predicts Will Rally By More Than 150%
4 years ago - By: Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
4 years ago - By: Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides a Corporate Update
4 years ago - By: Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals Reports Fourth Quarter and Full Year 2020 Financial Results and Provides a Corporate Update
4 years ago - By: Catabasis Pharmaceuticals, Inc.
Catabasis Pharmaceuticals To Present At Upcoming Investor Conferences
Please enable JavaScript to continue using this application.